Literature DB >> 813223

Isoimmunization against human chorionic gonadotropin with conjugates of processed beta-subunit of the hormone and tetanus toxoid.

G P Talwar, N C Sharma, S K Dubey, M Salahuddin, C Das, S Ramakrishnan, S Kumar, V Hingorani.   

Abstract

The immunogenicity of the conjugate prepared from "processed" beta-subunit of human chorionic gonadotropin (choriogonadotropin, HCG) and tetanus toxoid has been studied in animals and a human subject. The conjugate elicited the formation of high-affinity (Ka = 10(9)-10(11) M-1) anti-HCG and anti-tetanus antibodies. On primary immunization, the antibody, response lasted for several months. Repeat injection of the conjugate in the declining phase of antibody titers produced a booster response without a lag period. The antibodies reacted with the beta-subunit of HCG and the complete HCG molecule but were devois of significant crossreactivity with human growth hormone, placental lactogen, follicle-stimulating hormone, thyroid-stimulating hormone, and luteinizing hormone at tonic and surge levels. The antibodies were competent for neutralizing the biological activity of HCG in the mouse uterine weight gain assay, the ventral prostate weight gain assay, and the radioligand assay for binding of 125I-labeled HCG to receptors on corpus luteum. HCG (5000 international units) administered to an immunized subject was completely bound by circulating antibodies. Administration of HCG (in contrast to conjugate) was without booster effect on anti-HCG titers.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 813223      PMCID: PMC335872          DOI: 10.1073/pnas.73.1.218

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  Radioreceptor assay of human chorionic gonadotropin: detection of early pregnancy.

Authors:  B B Saxena; S H Hasan; F Haour; M Schmidt-Gollwitzer
Journal:  Science       Date:  1974-05-17       Impact factor: 47.728

2.  In vivo and in vitro production of human chorionic gonadotropin and alpha-feteoprotein by a virilizing hepatoblastoma.

Authors:  G D Braunstein; W E Bridson; A Glass; E W Hull; K R McIntire
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

3.  Absence of neutralizing effect of antisera to the unique structural region of human chorionic gonadotropin.

Authors:  J P Louvet; G T Ross; S Birken; R E Canfield
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

Review 4.  Radioimmunoassay.

Authors:  D S Skelley; L P Brown; P K Besch
Journal:  Clin Chem       Date:  1973-02       Impact factor: 8.327

5.  Ectopic production of human chorionic gonadotrophin by neoplasms.

Authors:  G D Braunstein; J L Vaitukaitis; P P Carbone; G T Ross
Journal:  Ann Intern Med       Date:  1973-01       Impact factor: 25.391

6.  Effects of immunization with hapten-coupled HCG on the human menstrual cycle.

Authors:  V C Stevens; C D Crystle
Journal:  Obstet Gynecol       Date:  1973-10       Impact factor: 7.661

7.  A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone.

Authors:  J L Vaitukaitis; G D Braunstein; G T Ross
Journal:  Am J Obstet Gynecol       Date:  1972-07-15       Impact factor: 8.661

8.  Immunization of female baboons with hapten-coupled gonadotropins.

Authors:  V C Stevens
Journal:  Obstet Gynecol       Date:  1973-10       Impact factor: 7.661

Review 9.  Studies of human chorionic gonadotropin.

Authors:  R E Canfield; F J Morgan; S Kammerman; J J Bell; G M Agosto
Journal:  Recent Prog Horm Res       Date:  1971

10.  Neutralizing and non-neutralizing antibodies to bovine thyroid-stimulating hormone and its subunits.

Authors:  G N Beall; I J Chopra; D H Solomon; J G Pierce; J S Cornell
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

View more
  19 in total

1.  A practicable immunological approach to block spermatogenesis without loss of androgens.

Authors:  G P Talwar; R K Naz; C Das; R P Das
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

2.  Recognition of the beta-subunit of human chorionic gonadotropin and sub-determinants by target tissue receptors.

Authors:  S Ramakrishnan; C Das; G P Talwar
Journal:  Biochem J       Date:  1978-11-15       Impact factor: 3.857

3.  A destiny to fulfill.

Authors:  G P Talwar
Journal:  J Biosci       Date:  2005-09       Impact factor: 1.826

4.  Targeting vaccinia virus-expressed secretory beta subunit of human chorionic gonadotropin to the cell surface induces antibodies.

Authors:  J Srinivasan; O Singh; S Chakrabarti; G P Talwar
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

Review 5.  Tetanus toxin.

Authors:  B Bizzini
Journal:  Microbiol Rev       Date:  1979-06

6.  Tomorrow's contraceptives--yesterday's problem.

Authors: 
Journal:  Br Med J       Date:  1979-10-20

7.  A shot at contraception: In India, a nonagenarian renews testing of a birth control vaccine.

Authors:  Killugudi Jayaraman
Journal:  Nat Med       Date:  2018-02-07       Impact factor: 53.440

Review 8.  Contraceptive vaccines.

Authors:  Rajesh K Naz
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Effect of amino group modification of ovine luteinizing hormone (oLH) by N-succinimidyl 6-[3-(2-pyridyldithio)propionate]hexanoate, a long chain N-succinimidyl-3-(2-pyridyldithio) propionate (SPDP) on immunological and biological properties: a comparative study with SPDP modified oLH.

Authors:  V Singh; R Curtiss
Journal:  Mol Cell Biochem       Date:  1994-01-12       Impact factor: 3.396

10.  Biodegradable delivery system for a birth control vaccine: immunogenicity studies in rats and monkeys.

Authors:  M Singh; O Singh; G P Talwar
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.